AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today the enrollment of the first patient in the company’s ALARION-EV study (NCT07324031).